Life Molecular Drug Patent Portfolio
Life Molecular owns 1 orange book drug protected by 2 US patents Given below is the list of Life Molecular's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7807135 | Stilbene derivatives and their use for binding and imaging amyloid plaques | 18 Mar, 2029 | Active |
| US7907135 | Image display and image displaying method for gradation correction | 18 Mar, 2029 | Active |
Latest Legal Activities on Life Molecular's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Life Molecular.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Apr, 2022 | US7907135 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 05 Apr, 2022 | US7807135 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 Sep, 2018 | US7907135 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Apr, 2018 | US7807135 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Nov, 2012 | US7807135 |
|
Correspondence Address Change
Critical
| 04 Nov, 2012 | US7807135 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Mar, 2011 | US7907135 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Mar, 2011 | US7907135 |
|
Issue Notification Mailed
Critical
| 23 Feb, 2011 | US7907135 |
| Printer Rush- No mailing | 11 Feb, 2011 | US7907135 |
|
Pubs Case Remand to TC
Critical
| 10 Feb, 2011 | US7907135 |
| Dispatch to FDC | 02 Feb, 2011 | US7907135 |
|
Application Is Considered Ready for Issue
Critical
| 28 Jan, 2011 | US7907135 |
|
Issue Fee Payment Received
Critical
| 27 Jan, 2011 | US7907135 |
|
Issue Fee Payment Verified
Critical
| 27 Jan, 2011 | US7907135 |
Life Molecular's Family Patents
Life Molecular drugs have patent protection in a total of 26 countries. It's US patent count contributes only to 20.0% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Life Molecular Drug List
Given below is the complete list of Life Molecular's drugs and the patents protecting them.
1. Neuraceq
Neuraceq is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7807135 | Stilbene derivatives and their use for binding and imaging amyloid plaques |
18 Mar, 2029
(4 years from now)
| Active |
| US7907135 | Image display and image displaying method for gradation correction |
18 Mar, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neuraceq's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List